Lanthanum carbonate versus placebo for management of hyperphosphatemia in patients undergoing peritoneal dialysis: a subgroup analysis of a phase 2 randomized controlled study of dialysis patients

BACKGROUND: This short-term study assessed the efficacy and safety of lanthanum carbonate in the treatment of hyperphosphatemia in dialysis patients; here, we report a prespecified subgroup analysis of patients undergoing peritoneal dialysis. METHODS: Men and women (n = 39) who had received continuo...

Descripción completa

Detalles Bibliográficos
Autores principales: Hutchison, Alastair J, Gill, Maggie, Copley, J Brian, Poole, Lynne, Wilson, Rosamund J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3582545/
https://www.ncbi.nlm.nih.gov/pubmed/23418668
http://dx.doi.org/10.1186/1471-2369-14-40

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3582545/
https://www.ncbi.nlm.nih.gov/pubmed/23418668
http://dx.doi.org/10.1186/1471-2369-14-40

Ejemplares similares